Moderna Inc annual earnings per share (EPS) for fiscal TTM was $-8.15, a decrease of 12.4% from $-7.25 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-8.15 | $-7.25 | $-9.27 | $-12.34 | $20.10 | $28.31 | $-1.96 | $-1.55 | $-4.74 | $-0.68 | $-0.58 | $-0.02 | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-3.40 | $-2.11 | $-0.51 | $-2.13 | $-2.52 | $-2.91 | $0.03 | $-3.33 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More MRNA metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All MRNA financial statements → Interactive MRNA charts →
About TickerBase · Data methodology & sources